Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC [Phase 2]
Phase 2 clinical trial comparing pembrolizumab after SBRT versus pembrolizumab alone in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study [Phase 2]
Phase II randomized study evaluating sintilimab with or without radiotherapy in recurrent or stage IV non-small cell lung cancer after plati…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer [Phase 2]
Phase 2 multicenter trial of rociletinib in patients with previously treated mutant EGFR non-small cell lung cancer (terminated; results pos…
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Mutation [Phase 3]
Phase 3 trial evaluating almonertinib in combination with chemotherapy as first-line therapy for EGFR mutation with concomitant tumor suppre…
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC [Phase 3]
Phase 3 trial exploring almonertinib plus chemotherapy as first-line treatment for EGFR-mutant NSCLC with concomitant non-EGFR driver mutati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance [Phase 2]
A Phase 2 clinical trial evaluating gefitinib combined with chemotherapy or anti-angiogenesis therapy in non-small-cell lung cancer patients…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel and carboplatin with or without celecoxib before surgery in stage IIIA non-small cell lung cancer has co…
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial evaluating CS-7017 in combination with erlotinib in stage IIIb/IV non-small cell lung cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial comparing hypoxia PET tracers FAZA and F-miso in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis [Phase 1]
Phase 1 clinical trial investigating cryotherapy for patients with primary stage I non-small cell lung cancer or lung metastasis; completed …
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating sintilimab after stereotactic ablation brachytherapy for refractory oligometastatic non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D [Phase 2]
Phase 2 clinical trial evaluating bortezomib in KRAS-mutant non-small cell lung cancer in never smokers or KRAS G12D patients has been compl…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Efficacy and Safety of Toripalimab (JS001) Combined With Pemetrexed and Anlotinib for Patients With T790M Positive Non-Small Cell Lung Cancer After Osimertinib Resistance [Phase 2]
Phase 2 trial evaluating toripalimab with pemetrexed and anlotinib in T790M-positive non-small cell lung cancer after osimertinib resistance…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Apatinib Combined With Chemotherapy for NSCLC Patients Without T790M Mutation [Phase 2]
Phase 2 clinical trial update evaluating apatinib combined with chemotherapy in non-small cell lung cancer patients without EGFR T790M mutat…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT) [Phase 1, Phase 2]
Clinical trial update for Tepotinib with Gefitinib in locally advanced or metastatic non-small cell lung cancer (INSIGHT) has completed phas…
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A phase 1/2 trial evaluating veliparib with paclitaxel/carboplatin-based chemoradiotherapy, followed by consolidation, in adults with stage …
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating erlotinib, paclitaxel, and carboplatin with radiation therapy for stage III non-small cell lung cancer has comple…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy [Phase 2]
Phase 2 clinical trial evaluating minocycline in conjunction with chemoradiation for non-small cell lung cancer has completed with results p…
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation [Phase 1, Phase 2]
Phase I/II clinical trial update for FCN-411 in advanced non-small cell lung cancer with EGFR mutation in Chinese patients.
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating tislelizumab with chemoradiotherapy followed by tislelizumab alone in newly diagnosed, stage III unresectable non-s…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer [NA]
A terminated randomized trial comparing CyberKnife radiotherapy to surgical resection in stage I non-small cell lung cancer has results post…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Pazopanib in Molecularly Selected Patients With Advanced NSCLC [Phase 2]
Phase 2 trial update of Pazopanib in molecularly selected patients with advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Neoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating Mutation [Phase 2]
Phase 2 trial exploring neoadjuvant afatinib in combination with chemotherapy for stage IIa-IIIb non-small cell lung cancer with EGFR activa…
-
CLINICAL_TRIALS trial_result · 2020-07-10Clinical Trial Update: Efficacy and Safety of CRT, Durvalumab and Surgery for SST [Phase 3]
Phase 3 trial evaluating CRT, durvalumab, and surgery for superior sulcus tumor in non-small cell lung cancer (stage IIB/III).
-
CLINICAL_TRIALS trial_result · 2020-07-10Clinical Trial Update: S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC [Phase 2]
Phase 2 trial evaluating S-1 plus gefitinib versus gefitinib alone in EGFR-mutant advanced non-squamous non-small cell lung cancer.